Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 19, 1997

View Archived Issues

Antidiabetic activity of beta3-adrenoceptor agonist BRL-37344 elucidated in vitro

Natural chemopreventive agent evaluated in rodent tumorigenesis models

Guilford presents preclinical results with PARP inhibitor

Lilly describes another SERM derived from raloxifene

Mitsubishi comes up with a new conjugate of 17beta-estradiol and a bisphosphonate

PTH analogue restores bone mass in rabbits with glucocorticoid-induced osteopenia

Efficacy of GAX-65 demonstrated in pediatric study

Dual IL-6/NO production inhibitors prepared at Takeda

Janssen discloses new tachykinin antagonists

Fournier presents new bradykinin antagonists

New cephalosporins from Il-Dong

Glaxo Wellcome develops glucocorticoids with favorable side effect profile

GH secretagogues for osteoporosis

OGS compound for glycolipid storage disorders nears clinic

Tiqueside inhibits cholesterol absorption and reduces LDL cholesterol in humans

Abbott investment to fund lupus drug candidate

New NO donor-containing NSAID derivatives from NitroMed

Taisho/Nihon Nohyaku identify potent and selective D4 receptor ligands

Lilly describes lead for orally active thrombin inhibitors

Draximage commences operations

Potent and selective 5-HT1D agonists under development at MS&D

Trinity Biotech's rotavirus test kit approved by FDA

Advisory committee recommends approval of Photofrin for early-stage NSCLC

Clinical update on Dermagraft

Canadian clearance for CEA-Scan

Oncogene Science changes name

New antiapoptosis gene identified at Yale

Tacrolimus ointment effective in animal model of contact dermatitis

Orphan drug status sought for Xerecept

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...